JG
BIO icon

Jefferies Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Jefferies Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,600
Closed -$2.11M – 2324
2016
Q4 		$2.11M Sell
11,600
-9,000
-44% -$1.53M 0.01% 925
2016
Q3 		$3.37M Buy
+20,600
New +$3.13M 0.02% 693

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jefferies Group's BIO Position: Q3 2022 in Review

Jefferies Group sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2022, closing a stake of 417 shares — an estimated $206K sold.

Jefferies Group first reported a position in BIO in Q2 2014 and held it in 25 quarters. The position peaked at $4.07M in Q1 2019. 485 funds tracked by Wall St. Rank hold BIO as of Q3 2022.

  • Jefferies Group reported no remaining Bio-Rad Laboratories Class A position as of Q3 2022 after selling out during the quarter.
  • Jefferies Group sold 417 Bio-Rad Laboratories Class A shares in Q3 2022, an estimated $206K.
  • Jefferies Group first reported a position in Bio-Rad Laboratories Class A in Q2 2014 and held it in 25 quarters.
  • Jefferies Group's Bio-Rad Laboratories Class A position peaked at $4.07M in Q1 2019.
  • 485 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.